CLINICAL TRIALS PROFILE FOR DIENOGEST; ESTRADIOL VALERATE
✉ Email this page to a colleague
All Clinical Trials for dienogest; estradiol valerate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00293059 ↗ | Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding | Completed | Bayer | Phase 3 | 2005-12-01 | The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding. |
NCT00307801 ↗ | Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding | Completed | Bayer | Phase 3 | 2006-02-01 | The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding. |
NCT00335218 ↗ | Fat Distribution in Healthy Early Postmenopausal Women | Completed | Bayer | Phase 4 | 2002-07-01 | The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging. |
NCT00764881 ↗ | Effects of SH T00658ID on Libido | Completed | Bayer | Phase 3 | 2009-01-01 | The aim of the study is to investigate whether women on oral contraceptives (OCs) suffering from acquired OC-associated female sexual dysfunction (FSD) for at least 3 months but no longer than one year will express the same level of sexual distress when taking SH T00658ID compared to Microgynon, the usual OC prescribed for women with OC-associated FSD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for dienogest; estradiol valerate
Condition Name
Clinical Trial Locations for dienogest; estradiol valerate
Trials by Country
Clinical Trial Progress for dienogest; estradiol valerate
Clinical Trial Phase
Clinical Trial Sponsors for dienogest; estradiol valerate
Sponsor Name